About this trial
To assess the effectiveness and security of a mobile App (beta version) for self-managing emotion dysregulation in a pragmatic randomized controlled trial with 80 adolescents with attention-deficit/hyperactivity disorder comparing 40 patients with treatment as usual (TAU) with 40 patients with TAU plus the mobile App
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) of attention-deficit/hyperactivity disorder
High emotion dysregulation severity
Aged 14 to 17 years
Outpatient setting (Consorci Sanitari del Maresme
Disqualifiers
Comorbidity with mental retardation
Comorbidity with psychotic disorder
Comorbidity with autism spectrum disorder
Trial design
Parallel
Treatments tested in this trial
Mobile app
DeviceMedical device for improving emotion dysregulation
Treatment as usual
Combination productBimonthly individual psychotherapy and psychostimulant medications
Treatment groups
Trial outcomes
Primary outcomes
Emotion dysregulation severity
Severity of emotional dysregulation as measured by a single score from the The DERS (Difficulties in Emotion Regulation Scale) (range: 0-88; the higher the score, the more severe the emotion dysregulation severity).
Smartphone addiction
Severity of smartphone addiction as measured by the Spanish version of the The Smartphone Addiction Scale (SAS) (range: 10-60; the higher the score, the more severe the smartphone addiction severity).
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: